Skip to main content
星昊医药 logo

星昊医药 — Investor Relations & Filings

Ticker · 920017 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-07-17 Governance Information
Country CN China
Listing Beijing Stock Exchange 920017

About 星昊医药

https://www.sunho.com.cn/

Beijing Sunho Pharmaceutical Co., Ltd. is a technology-driven enterprise specializing in the research, development, manufacturing, and commercialization of advanced pharmaceutical preparations. The company focuses on high-barrier drug delivery systems, including sustained-release, controlled-release, and complex injection technologies. Its core business encompasses the production of a diverse portfolio of chemical drugs and biological products, alongside comprehensive Contract Development and Manufacturing Organization (CDMO) services. Sunho Pharmaceutical operates modern, GMP-compliant production facilities designed to support the entire lifecycle of drug development, from pilot-scale testing to large-scale commercial manufacturing. By leveraging its proprietary formulation platforms, the company provides integrated solutions for complex dosage forms, catering to both domestic and international pharmaceutical markets.

Recent filings

Filing Released Lang Actions
董事会薪酬与考核委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Remuneration and Assessment Committee Work Rules' of Beijing Xinghao Pharmaceutical Co., Ltd. It details the internal rules, responsibilities, composition, and procedures of the board's remuneration and assessment committee. There is no financial data, no report of financial results, no voting results, no announcement of a report publication, nor any regulatory certification. The content focuses on governance structure and internal board committee rules, which aligns with governance information. The document length is 3388 characters, which is relatively short but contains substantive governance content, not just an announcement. Therefore, the appropriate classification is Governance Information (CGR).
2025-07-17 Chinese
年报信息披露重大差错责任追究制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '年报信息披露重大差错责任追究制度' (Annual Report Information Disclosure Major Error Responsibility Pursuit System) issued by the company's board. It outlines the responsibilities, principles, and procedures for handling major errors in annual report disclosures, including accountability measures for company personnel. It does not contain actual financial data or the annual report itself, nor is it an announcement of a report publication. Instead, it is a governance-related document focused on internal control and accountability regarding annual report disclosures. Therefore, it fits best under Governance Information (CGR). The document length is 3675 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification.
2025-07-17 Chinese
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled as "北京星昊医药股份有限公司董事会秘书工作细则" which translates to "Beijing Xinghao Pharmaceutical Co., Ltd. Board Secretary Work Rules." It details the qualifications, duties, appointment, and responsibilities of the company's board secretary. The content is about internal governance rules and procedures related to the board secretary role, including compliance with laws and regulations, reporting obligations, and internal management. There is no financial data, no audit information, no voting results, no earnings or capital updates, and no mention of shareholder meetings or report publications. The document is a governance-related internal policy document rather than a report or announcement. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3857 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2025-07-17 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '北京星昊医药股份有限公司会计师事务所选聘制度' which translates to 'Beijing Xinghao Pharmaceutical Co., Ltd. Auditor Selection System'. It outlines the procedures, qualifications, responsibilities, and supervisory mechanisms for selecting and appointing the company's external audit firm. It includes governance and procedural details about audit firm selection, evaluation, appointment, and replacement, but does not contain any financial statements, audit opinions, or actual audit reports. It is not an announcement of a report but a governance/internal management document related to audit firm selection. Therefore, it fits best under 'Governance Information (CGR)' which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-07-17 Chinese
承诺管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system related to commitment management for Beijing Xinghao Pharmaceutical Co., Ltd. It includes sections on the company's commitment management policies, rights and obligations of the commitment makers, and procedural rules. It is not a financial report, earnings release, or regulatory filing about financial results. It is also not an announcement of voting results or a proxy solicitation. The document is a governance-related policy document detailing internal rules and governance practices of the company. Therefore, it fits best under Governance Information (CGR). The document length is 2603 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, the classification is CGR with high confidence.
2025-07-17 Chinese
股东会议事规则
Governance Information Classification · 100% confidence The document is titled as "北京星昊医药股份有限公司股东会议事规则" which translates to "Beijing Xinghao Pharmaceutical Co., Ltd. Shareholders Meeting Rules." It contains detailed rules and procedures governing the conduct of shareholders' meetings, including the rights and responsibilities of shareholders, the process for convening meetings, voting procedures, and other governance-related matters. There is no financial data, earnings information, or audit content. It is not a report of financial results or an announcement of voting results. Instead, it is a governance document detailing internal rules and procedures related to shareholder meetings and corporate governance. Therefore, the document fits the category of Governance Information (CGR). The document length (9970 characters) and content confirm it is a full governance report, not a brief announcement or notice.
2025-07-17 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.